Valeant Pharmaceuticals And Bill Ackman Have Their Day In Washington

Fresh off one of the biggest Wall Street drubbings in recent memory, Valeant Pharmaceuticals is in to Washington to defend itself against accusations the company is little more than a price-gouging, drug industry hedge fund of sorts.